<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">33842517</PMID><DateRevised><Year>2021</Year><Month>04</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>8</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Ross River Virus Immune Evasion Strategies and the Relevance to Post-viral Fatigue, and Myalgic Encephalomyelitis Onset.</ArticleTitle><Pagination><StartPage>662513</StartPage><MedlinePgn>662513</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">662513</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2021.662513</ELocationID><Abstract><AbstractText>Ross River virus (RRV) is an endemic Australian arbovirus, and member of the Alphavirus family that also includes Chikungunya virus (CHIK). RRV is responsible for the highest prevalence of human disease cases associated with mosquito-borne transmission in Australia, and has long been a leading suspect in cases of post-viral fatigue syndromes, with extrapolation of this link to Myalgic Encephalomyelitis (ME). Research into RRV pathogenesis has revealed a number of immune evasion strategies, impressive for a virus with a genome size of 12 kb (plus strand RNA), which resonate with insights into viral pathogenesis broadly. Drawing from observations on RRV immune evasion, mechanisms of relevance to long term idiopathic fatigue are featured as a perspective on infection and eventual ME symptoms, which include considerations of; (1) selective pro-inflammatory gene suppression post antibody-dependent enhancement (ADE) of RRV infection, (2) Evidence from other virus families of immune disruption and evasion post-ADE, and (3) how virally-driven immune evasion may impact on mitochondrial function via target of rapamycin (TOR) complexes. In light of these RRV measures to counter the host immune - inflammatory responses, links to recent discoveries explaining cellular, immune and metabolomic markers of ME will be explored and discussed, with the implications for long-COVID post SARS-CoV-2 also considered. Compelling issues on the connections between virally-induced alterations in cytokine expression, for example, will be of particular interest in light of energy pathways, and how these perturbations manifest clinically.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Lidbury.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lidbury</LastName><ForeName>Brett A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>National Centre for Epidemiology and Population Health, Research School of Population Health, The Australian National University, Canberra, ACT, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">immunity</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">virus</Keyword></KeywordList><CoiStatement>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33842517</ArticleId><ArticleId IdType="pmc">PMC8024622</ArticleId><ArticleId IdType="doi">10.3389/fmed.2021.662513</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics. (2019) 9:91. 10.3390/diagnostics9030091</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030091</ArticleId><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. . Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270:327&#x2013;38. 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif K, Watad A, Bragazzi NL, Lichtbroun M, Martini M, Perricone C, et al. . On chronic fatigue syndrome and nosological categories. Clin Rheumatol. (2018) 37:1161&#x2013;70. 10.1007/s10067-018-4009-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4009-2</ArticleId><ArticleId IdType="pubmed">29417255</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Chronic fatigue syndromes: relationship to chronic viral infections. J Virol Methods. (1988) 21:3&#x2013;10. 10.1016/0166-0934(88)90047-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0166-0934(88)90047-X</ArticleId><ArticleId IdType="pubmed">2846619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. . Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. (2018) 16:268. 10.1186/s12967-018-1644-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Raijmakers RPH, Roerink ME, Jansen AFM, Keijmel SP, Gacesa R, Li Y, et al. . Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome. J Transl Med. (2020) 18:448. 10.1186/s12967-020-02585-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02585-5</ArticleId><ArticleId IdType="pmc">PMC7690002</ArticleId><ArticleId IdType="pubmed">33243243</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. (2006) 333:575. 10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Knipe DM, Howley PM. (Editors-in-chief) Field's Virology. Associate editors, Jeffrey I, Cohen et al. 6th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams &amp; Wilkins; (2013).</Citation></Reference><Reference><Citation>Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL. Viral subversion of the immune system. Annu Rev Immunol. (2000) 18:861&#x2013;926. 10.1146/annurev.immunol.18.1.861</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.18.1.861</ArticleId><ArticleId IdType="pubmed">10837078</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannello A, Debbeche O, Martin E, Attalah LH, Samarani S, Ahmad A. Viral strategies for evading antiviral cellular immune responses of the host. J Leukoc Biol. (2006) 79:16&#x2013;35. 10.1189/jlb.0705397</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0705397</ArticleId><ArticleId IdType="pubmed">16204622</ArticleId></ArticleIdList></Reference><Reference><Citation>Upton C, Mossman K, McFadden G. Encoding of a homolog of the IFN-gamma receptor by Myxoma virus. Science. (1992) 258:1369. 10.1126/science.1455233</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1455233</ArticleId><ArticleId IdType="pubmed">1455233</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcami A, Smith GL. A soluble receptor for interieukin-1&#x3b2; encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection. Cell. (1992) 71:153&#x2013;67. 10.1016/0092-8674(92)90274-G</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(92)90274-G</ArticleId><ArticleId IdType="pubmed">1394428</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore KW, Fiorentino DF, Trounstine ML, Khan TA, Mossmann TR. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Ban- virus gene BCRFI. Science. (1990) 248:1230&#x2013;4. 10.1126/science.2161559</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.2161559</ArticleId><ArticleId IdType="pubmed">2161559</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris SL, Frank I, Yee A, Cohen GH, Eisenberg RJ, Friedman HM. Glycoprotein C of herpes simplex virus, type I prevents complement-mediated cell lysis and virus neutralisation. J Infect Dis. (1990) 162:331&#x2013;7. 10.1093/infdis/162.2.331</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/162.2.331</ArticleId><ArticleId IdType="pubmed">2165106</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidbury BA. Was exposure to directly antiviral cytokines during primary infection an important selective pressure in the evolution of unique immune evasion strategies by viruses? Immunol Cell Biol. (1994) 72:347&#x2013;50. 10.1038/icb.1994.52</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.1994.52</ArticleId><ArticleId IdType="pubmed">7528723</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaston TB, Lidbury BA. Genetic &#x201c;budget&#x201d; of viruses and the cost to the infected host: a theory on the relationship between the genetic capacity of viruses, immune evasion, persistence and disease. Immunol Cell Biol. (2001) 79:62&#x2013;6. 10.1046/j.1440-1711.2001.00973.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1440-1711.2001.00973.x</ArticleId><ArticleId IdType="pubmed">11168625</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalingam S, Meanger J, Foster PS, Lidbury BA. The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses. J Leukoc Biol. (2002) 72:429&#x2013;39. 10.1189/jlb.72.3.429</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.72.3.429</ArticleId><ArticleId IdType="pubmed">12223509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bos S, Poirier-Beaudouin B, Seffer V, Manich M, Mardi C, Despr&#xe8;s P, et al. . Zika virus inhibits IFN-&#x3b1; response by human plasmacytoid dendritic cells and induces NS1-dependent triggering of CD303 (BDCA-2) signaling. Front Immunol. (2020) 11:582061. 10.3389/fimmu.2020.582061</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.582061</ArticleId><ArticleId IdType="pmc">PMC7655658</ArticleId><ArticleId IdType="pubmed">33193389</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye J, Zhu B, Fu ZF, Chen H, Cao S. Immune evasion strategies of flaviviruses. Vaccine. (2013) 31:461&#x2013;71. 10.1016/j.vaccine.2012.11.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.11.015</ArticleId><ArticleId IdType="pubmed">23153447</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouayad A. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV. Rev Med Virol. (2020) 30:1&#x2013;9. 10.1002/rmv.2135</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2135</ArticleId><ArticleId IdType="pubmed">32734714</ArticleId></ArticleIdList></Reference><Reference><Citation>Taefehshokr N, Taefehshokr S, Hemmat N, Heit B. Covid-19: perspectives on innate immune evasion. Front Immunol. (2020) 11:580641. 10.3389/fimmu.2020.580641</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.580641</ArticleId><ArticleId IdType="pmc">PMC7554241</ArticleId><ArticleId IdType="pubmed">33101306</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley D, Sleigh A, Ritchie S. Ross river virus transmission, infection, and disease: a cross-disciplinary review. Clin Microbiol Rev. (2001) 14:909&#x2013;32. 10.1128/CMR.14.4.909-932.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.14.4.909-932.2001</ArticleId><ArticleId IdType="pmc">PMC89008</ArticleId><ArticleId IdType="pubmed">11585790</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhrbier A, Jaffar-Bandjee MC, Gasque P. Arthritogenic alphaviruses&#x2013;an overview. Nat Rev Rheumatol. (2012) 8:420&#x2013;9. 10.1038/nrrheum.2012.64</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2012.64</ArticleId><ArticleId IdType="pubmed">22565316</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature Editorial. Long COVID: let patients help define long-lasting COVID symptoms. Nature. (2020) 586:170. 10.1038/d41586-020-02796-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02796-2</ArticleId><ArticleId IdType="pubmed">33029005</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes RA. Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls. Aust J Exp Biol Med Sci. (1964) 42:465&#x2013;82. 10.1038/icb.1964.44</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/icb.1964.44</ArticleId><ArticleId IdType="pubmed">14202187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes RA, Lafferty KJ. The enhancement of virus infectivity by antibody. Virology. (1967) 33:250&#x2013;61. 10.1016/0042-6822(67)90144-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(67)90144-4</ArticleId><ArticleId IdType="pubmed">6053142</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, O'Rourke EJ. Dengue viruses and mononuclear phagocytes. I Infection enhancement by non-neutralizing antibody. J Exp Med. (1977) 146:201&#x2013;17. 10.1084/jem.146.1.201</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.146.1.201</ArticleId><ArticleId IdType="pmc">PMC2180729</ArticleId><ArticleId IdType="pubmed">406347</ArticleId></ArticleIdList></Reference><Reference><Citation>Peiris JS, Gordon S, Unkeless JC, Porterfield JS. Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages. Nature. (1981) 289:189&#x2013;91. 10.1038/289189a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/289189a0</ArticleId><ArticleId IdType="pubmed">7453820</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlesinger JJ, Brandriss MW. 17D yellow fever virus infection of P388D1 cells mediated by monoclonal antibodies: properties of the macrophage Fc receptor. J Gen Virol. (1983) 64 (Pt 6):1255&#x2013;62. 10.1099/0022-1317-64-6-1255</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-64-6-1255</ArticleId><ArticleId IdType="pubmed">6854270</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue haemorrhagic fever. Am J Trop Med Hyg. (1989) 40:444&#x2013;51. 10.4269/ajtmh.1989.40.444</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1989.40.444</ArticleId><ArticleId IdType="pubmed">2712199</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla R, Beesetti H, Brown JA, Ahuja R, Ramasamy V, Shanmugam RK, et al. . Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models. EBioMedicine. (2020) 60:102991. 10.1016/j.ebiom.2020.102991</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102991</ArticleId><ArticleId IdType="pmc">PMC7501058</ArticleId><ArticleId IdType="pubmed">32949997</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor A, Foo SS, Bruzzone R, Dinh LV, King NJ, Mahalingam S. Fc receptors in antibody-dependent enhancement of viral infections. Immunol Rev. (2015) 268:340&#x2013;64. 10.1111/imr.12367</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12367</ArticleId><ArticleId IdType="pmc">PMC7165974</ArticleId><ArticleId IdType="pubmed">26497532</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirado SM, Yoon KJ. Antibody-dependent enhancement of virus infection and disease. Viral Immunol. (2003) 16:69&#x2013;86. 10.1089/088282403763635465</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/088282403763635465</ArticleId><ArticleId IdType="pubmed">12725690</ArticleId></ArticleIdList></Reference><Reference><Citation>Porterfield JS. Antibody-dependent enhancement of viral infectivity. In: Maramorosch K, Murphy FA, Shatkin AJ. editors. Advances in Virus Research. Vol. 31. Cambridge, MA: Academic Press; (1986). p. 335&#x2013;55. 10.1016/S0065-3527(08)60268-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(08)60268-7</ArticleId><ArticleId IdType="pubmed">2428214</ArticleId></ArticleIdList></Reference><Reference><Citation>Linn ML, Aaskov JG, Suhrbier A. Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis. J Gen Virol. (1996) 77 (Pt 3):407&#x2013;11. 10.1099/0022-1317-77-3-407</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-77-3-407</ArticleId><ArticleId IdType="pubmed">8601774</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidbury BA, Mahalingam S. Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection. J Virol. (2000) 74:8376&#x2013;81. 10.1128/JVI.74.18.8376-8381.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.18.8376-8381.2000</ArticleId><ArticleId IdType="pmc">PMC116348</ArticleId><ArticleId IdType="pubmed">10954537</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalingam S, Lidbury BA. Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc Natl Acad Sci USA. (2002) 99:13819&#x2013;24. 10.1073/pnas.202415999</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.202415999</ArticleId><ArticleId IdType="pmc">PMC129781</ArticleId><ArticleId IdType="pubmed">12364588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonsirisuthigul T, Kalayanarooj S, Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J Gen Virol. (2007) 88 (Pt 2):365&#x2013;75. 10.1099/vir.0.82537-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82537-0</ArticleId><ArticleId IdType="pubmed">17251552</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaway JB, Smith SA, McKinnon KP, de Silva AM, Crowe JE, Jr, Ting JP. Spleen tyrosine kinase (Syk) mediates IL-1&#x3b2; induction by primary human monocytes during antibody-enhanced dengue virus infection. J Biol Chem. (2015) 290:17306&#x2013;20. 10.1074/jbc.M115.664136</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.664136</ArticleId><ArticleId IdType="pmc">PMC4498069</ArticleId><ArticleId IdType="pubmed">26032420</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Yue Y, Li D, Zhao Y, Qiu L, Chen J, et al. . Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy. Sci Rep. (2016) 6:22303. 10.1038/srep22303</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22303</ArticleId><ArticleId IdType="pmc">PMC4770412</ArticleId><ArticleId IdType="pubmed">26923481</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai TT, Chuang YJ, Lin YS, Wan SW, Chen CL, Lin CF. An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. J Biomed Sci. (2013) 20:40. 10.1186/1423-0127-20-40</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-40</ArticleId><ArticleId IdType="pmc">PMC3700829</ArticleId><ArticleId IdType="pubmed">23800014</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai T-T, Chuang Y-J, Lin Y-S, Chang C-P, Wan S-W, Lin S-H, et al. . Antibody-dependent enhancement infection facilitates dengue virus-regulated signalling of IL-10 production in monocytes. PLoS Negl Trop Dis. (2014) 8:e3320. 10.1371/journal.pntd.0003320</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003320</ArticleId><ArticleId IdType="pmc">PMC4239119</ArticleId><ArticleId IdType="pubmed">25412261</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Li W, Sun Y, Kong L, Xu P, Xia P, et al. . Antibody-mediated porcine reproductive and respiratory syndrome virus infection downregulates the production of interferon-&#x3b1; and tumor necrosis factor-&#x3b1; in porcine alveolar macrophages via Fc gamma receptor I and III. Viruses. (2020) 12:187. 10.3390/v12020187</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12020187</ArticleId><ArticleId IdType="pmc">PMC7077232</ArticleId><ArticleId IdType="pubmed">32046249</ArticleId></ArticleIdList></Reference><Reference><Citation>Cancel-Tirado SM, Evans RB, Yoon KJ. Monoclonal antibody analysis of porcine reproductive and respiratory syndrome virus epitopes associated with antibody-dependent enhancement and neutralization of virus infection. Vet Immunol Immunopathol. (2004) 102:249&#x2013;62. 10.1016/j.vetimm.2004.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2004.09.017</ArticleId><ArticleId IdType="pmc">PMC7173136</ArticleId><ArticleId IdType="pubmed">15507309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao D, Wang R, Qiao S, Wan B, Wang Y, Liu M, et al. . Antibody-dependent enhancement of PRRSV infection down-modulates TNF-&#x3b1; and IFN-&#x3b2; transcription in macrophages. Vet Immunol Immunopathol. (2013) 156:128&#x2013;34. 10.1016/j.vetimm.2013.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetimm.2013.09.006</ArticleId><ArticleId IdType="pubmed">24099951</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao S, Jiang Z, Tian X, Wang R, Xing G, Wan B, et al. . Porcine Fc&#x3b3;RIIb mediates enhancement of porcine reproductive and respiratory syndrome virus (PRRSV) infection. PLoS ONE. (2011) 6:e28721. 10.1371/journal.pone.0028721</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0028721</ArticleId><ArticleId IdType="pmc">PMC3248417</ArticleId><ArticleId IdType="pubmed">22220194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao YT, Lai MMC, Yu CY. How dengue virus circumvents innate immunity. Front Immunol. (2018) 9:2860. 10.3389/fimmu.2018.02860</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02860</ArticleId><ArticleId IdType="pmc">PMC6288372</ArticleId><ArticleId IdType="pubmed">30564245</ArticleId></ArticleIdList></Reference><Reference><Citation>King CA, Marshall JS, Alshurafa H, Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J Virol. (2000) 74:7146&#x2013;50. 10.1128/JVI.74.15.7146-7150.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.15.7146-7150.2000</ArticleId><ArticleId IdType="pmc">PMC112233</ArticleId><ArticleId IdType="pubmed">10888655</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuyama W, Nanbo A, Maruyama J, Marzi A, Takada A. A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection. PLoS Negl Trop Dis. (2020) 14:e0008602. 10.1371/journal.pntd.0008602</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0008602</ArticleId><ArticleId IdType="pmc">PMC7497997</ArticleId><ArticleId IdType="pubmed">32886656</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuyama W, Marzi A, Carmody AB, Maruyama J, Kuroda M, Miyamoto H, et al. . Fc&#x3b3;-receptor IIa-mediated Src signaling pathway Is essential for the antibody-dependent enhancement of Ebola virus infection. PLoS Pathog. (2016) 12:e1006139. 10.1371/journal.ppat.1006139</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006139</ArticleId><ArticleId IdType="pmc">PMC5231391</ArticleId><ArticleId IdType="pubmed">28036370</ArticleId></ArticleIdList></Reference><Reference><Citation>Takada A, Ebihara H, Feldmann H, Geisbert TW, Kawaoka Y. Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis. (2007) 196 (Suppl. 2):S347&#x2013;56. 10.1086/520581</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520581</ArticleId><ArticleId IdType="pubmed">17940970</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip MS, Leung HL, Li PH, Cheung CY, Dutry I, Li D, et al. . Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS. Hong Kong Med J. (2016) 22 (3 Suppl. 4):25&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">27390007</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip MS, Leung NHL, Cheung CY, Li PH, Lee HHY, Da&#xeb;ron M, et al. . Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus. Virol J. (2014) 11:82. 10.1186/1743-422X-11-82</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-82</ArticleId><ArticleId IdType="pmc">PMC4018502</ArticleId><ArticleId IdType="pubmed">24885320</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, et al. . Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc&#x3b3;R pathway. J Virol. (2011) 85:10582&#x2013;97. 10.1128/JVI.00671-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00671-11</ArticleId><ArticleId IdType="pmc">PMC3187504</ArticleId><ArticleId IdType="pubmed">21775467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bournazos S, Gupta A, Ravetch JV. The role of IgG Fc receptors in antibody-dependent enhancement. Nat Rev Immunol. (2020) 20:633&#x2013;43. 10.1038/s41577-020-00410-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00410-0</ArticleId><ArticleId IdType="pmc">PMC7418887</ArticleId><ArticleId IdType="pubmed">32782358</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkins PT, Stephens LR. PI3K signalling in inflammation. Biochim Biophys Acta. (2015) 1851:882&#x2013;97. 10.1016/j.bbalip.2014.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbalip.2014.12.006</ArticleId><ArticleId IdType="pubmed">25514767</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley JH, Harrison A, Corey A, Gentry N, Gregg RK. Ebola virus secreted glycoprotein decreases the anti-viral immunity of macrophages in early inflammatory responses. Cell Immunol. (2018) 324:24&#x2013;32. 10.1016/j.cellimm.2017.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2017.11.009</ArticleId><ArticleId IdType="pmc">PMC7094302</ArticleId><ArticleId IdType="pubmed">29195741</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloutier M, Nandi M, Ihsan AU, Chamard HA, Ilangumaran S, Ramanathan S. ADE and hyperinflammation in SARS-CoV2 infection - comparison with dengue hemorrhagic fever and feline infectious peritonitis. Cytokine. (2020) 136:155256. 10.1016/j.cyto.2020.155256</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155256</ArticleId><ArticleId IdType="pmc">PMC7439999</ArticleId><ArticleId IdType="pubmed">32866898</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JP, Klasse PJ. COVID-19 vaccines: &#x201c;Warp Speed&#x201d; needs mind melds, not warped minds. J Virol. (2020) 94:e01083&#x2013;e01020. 10.1128/JVI.01083-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01083-20</ArticleId><ArticleId IdType="pmc">PMC7431783</ArticleId><ArticleId IdType="pubmed">32591466</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W, et al. . Long-COVID: An evolving problem with an extensive impact. S Afr Med J. (2020) 111:10&#x2013;2 10.7196/SAMJ.2020.v111i11.15433</Citation><ArticleIdList><ArticleId IdType="doi">10.7196/SAMJ.2020.v111i11.15433</ArticleId><ArticleId IdType="pubmed">33403997</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Yang Y, Wang D, Li C, Qu Y, Guo J, et al. . The clinical value of cytokines in chronic fatigue syndrome. J Transl Med. (2019) 17:213. 10.1186/s12967-019-1948-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1948-6</ArticleId><ArticleId IdType="pmc">PMC6599310</ArticleId><ArticleId IdType="pubmed">31253154</ArticleId></ArticleIdList></Reference><Reference><Citation>Blundell S, Ray KK, Buckland M, White PD. Chronic fatigue syndrome and circulating cytokines: a systematic review. Brain Behav Immun. (2015) 50:186&#x2013;95. 10.1016/j.bbi.2015.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.07.004</ArticleId><ArticleId IdType="pubmed">26148446</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med. (2009) 2:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680051</ArticleId><ArticleId IdType="pubmed">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Brown A, Strassheim V, Elson JL, Newton J, Manning P. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PLoS ONE. (2017) 12:e0186802. 10.1371/journal.pone.0186802</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186802</ArticleId><ArticleId IdType="pmc">PMC5655451</ArticleId><ArticleId IdType="pubmed">29065167</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong CW, McGregor NR, Sheedy JR, Buttfield I, Butt HL, Gooley PR. NMR metabolic profiling of serum identifies amino acid disturbances in chronic fatigue syndrome. Clin Chim Acta. (2012) 413:1525&#x2013;31. 10.1016/j.cca.2012.06.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2012.06.022</ArticleId><ArticleId IdType="pubmed">22728138</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong CW, McGregor NR, Butt HL, Gooley PR. Metabolism in chronic fatigue syndrome. Adv Clin Chem. (2014) 66:121&#x2013;72. 10.1016/B978-0-12-801401-1.00005-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-801401-1.00005-0</ArticleId><ArticleId IdType="pubmed">25344988</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Annesley SJ, Allan CY, Sanislav O, Lidbury BA, Lewis DP, et al. . An isolated complex V inefficiency and dysregulated mitochondrial function in immortalized lymphocytes from ME/CFS patients. Int J Mol Sci. (2020) 21:1074. 10.3390/ijms21031074</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031074</ArticleId><ArticleId IdType="pmc">PMC7036826</ArticleId><ArticleId IdType="pubmed">32041178</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Sanislav O, Allan CY, Annesley SJ, Fisher PR. Cell-based blood biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Sci. (2020) 21:1142. 10.3390/ijms21031142</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031142</ArticleId><ArticleId IdType="pmc">PMC7037777</ArticleId><ArticleId IdType="pubmed">32046336</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewith R, Hall MN. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics. (2011) 189:1177&#x2013;201. 10.1534/genetics.111.133363</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.111.133363</ArticleId><ArticleId IdType="pmc">PMC3241408</ArticleId><ArticleId IdType="pubmed">22174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Weichhart T. mTOR as regulator of lifespan, aging, and cellular senescence: a mini-review. Gerontology. (2018) 64:127&#x2013;34. 10.1159/000484629</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000484629</ArticleId><ArticleId IdType="pmc">PMC6089343</ArticleId><ArticleId IdType="pubmed">29190625</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleiro D, Platanias LC. Intersection of mTOR and STAT signaling in immunity. Trends Immunol. (2015) 36:21&#x2013;9. 10.1016/j.it.2014.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2014.10.006</ArticleId><ArticleId IdType="pmc">PMC4297313</ArticleId><ArticleId IdType="pubmed">25592035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford EM, Ryu SH, Singh AP, Lee G, Goretsky T, Sinh P, et al. . Epithelial TNF receptor signaling promotes mucosal repair in inflammatory bowel disease. J Immunol. (2017) 199:1886&#x2013;97. 10.4049/jimmunol.1601066</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601066</ArticleId><ArticleId IdType="pmc">PMC5568528</ArticleId><ArticleId IdType="pubmed">28747340</ArticleId></ArticleIdList></Reference><Reference><Citation>Uysal H, Chavez-Galan L, Vesin D, Blaser G, Benkhoucha M, Ryffel B, et al. . Transmembrane TNF and partially TNFR1 regulate TNFR2 expression and control inflammation in mycobacterial-induced pleurisy. Int J Mol Sci. (2018) 19:1959. 10.3390/ijms19071959</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19071959</ArticleId><ArticleId IdType="pmc">PMC6073837</ArticleId><ArticleId IdType="pubmed">29973541</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidbury BA, Kita B, Lewis DP, Hayward S, Ludlow H, Hedger MP, et al. . Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study. J Transl Med. (2017) 15:60. 10.1186/s12967-017-1161-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1161-4</ArticleId><ArticleId IdType="pmc">PMC5353946</ArticleId><ArticleId IdType="pubmed">28302133</ArticleId></ArticleIdList></Reference><Reference><Citation>de Kretser DM, O'Hehir RE, Hardy CL, Hedger MP. The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair. Mol Cell Endocrinol. (2012) 359:101&#x2013;6. 10.1016/j.mce.2011.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2011.10.009</ArticleId><ArticleId IdType="pubmed">22037168</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>